RLMD
Relmada Therapeutics Inc.
$7.17
+$0.13(+1.85%)
50
Overall
60
Value
63
Tech
28
Quality
Market Cap
$50.78M
Volume
726.37K
52W Range
$0.36 - $8.00
Target Price
$12.80
EPS Estimates Overview
| Current Quarter | $-0.19 | Next Quarter | $-0.2 |
| Current Year | $-0.76 | Next Year | $-1.19 |
| QoQ Growth | -5.3% | YoY Growth | -56.6% |
| 3Y EPS CAGR | +35.1% | Target Price | $12.80 |
| Consensus | Buy | Upside | +78.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RLMD | $7.17 | +1.8% | 726.37K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Relmada Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW